23andMe
In Brief This Week: Sema4, Mirvie, Caris Life Sciences, Prenetics, 23andMe, More
News items for the week of May 2, 2022.
23andMe Fiscal Q3 Revenues Increase 3 Percent
Despite higher revenues due in part to the November acquisition of Lemonaid Health, the firm's net loss more than doubled in the quarter to $89.4 million.
23andMe Study Associates Gene Locus With COVID-19-Related Loss of Smell, Taste
A multi-ancestry genome-wide association study found that genetics likely contributes to the loss of smell or taste in COVID-19 patients.
23andMe Gets $50M Payment as GSK Extends Companies' Drug Discovery Alliance
The companies are using 23andMe's extensive genotype-phenotype database and other resources to identify targets for personalized therapeutics, continuing an alliance begun in 2018.
Nov 10, 2021
23andMe Fiscal Q2 Revenues Increase 7 Percent
Aug 13, 2021
23andMe Q1 Revenues Rise 23 Percent
Jul 21, 2021
May 26, 2021
Feb 26, 2021
Dec 29, 2020
23andMe Raises $82.5M in Private Financing
Nov 12, 2020
OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises
Aug 3, 2020